Plain-English translation of NCT07226869 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing Accublate, a computer software that guides doctors during microwave ablation—a minimally invasive procedure that uses heat to destroy liver cancer tumors. The software creates a 3D map of your tumor and shows the doctor in real-time exactly where the heat is reaching, helping ensure complete treatment of the cancer. Studies of similar guidance systems have shown better results, and this trial will test whether this approach works well for microwave ablation.
Liver cancer is often treated with heat-based procedures, but doctors have limited ways to see exactly how much of the tumor is being destroyed during treatment. This medication aims to solve that problem by giving doctors a real-time picture, which could lead to better cure rates and fewer repeat treatments.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you will undergo a microwave ablation procedure guided by the Accublate software at either Dartmouth Hitchcock Medical Center or another participating hospital. The procedure is performed while you're sedated and uses imaging to guide the treatment; doctors will use the computer software to plan the ablation beforehand and monitor it in real-time during the procedure. You will stay overnight in the hospital for observation, then return about one month later for a follow-up CT scan to confirm the cancer was completely treated.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
United States